Ergomed PLC (AIM:ERGO, ETR:2EM, FRA:2EM) Richard Barfield joins Proactive London's Katie Pilbeam about their 'great progress on delivering on strategy in first half of 2021'.
Total revenue climbed 39% to £56mln with adjusted underlying earnings (EBITDA) up 33% to £12mln. Cash at the end of June was £24mln with no debt.
Net new sales awards surged 51% and the order book of future contracted revenue jumped 50% to £227mln.
He highlights the continued strong organic growth and the successful integration of value-enhancing acquisitions with an increase in demand.